DSPE-PEG 2000 NEW
Price | $31 | $45 | $70 |
Package | 5mg | 10mg | 25mg |
Min. Order: | |
Supply Ability: | 10g |
Update Time: | 2024-11-18 |
Product Details
Product Name: DSPE-PEG 2000 | CAS No.: 892144-24-0 |
Supply Ability: 10g | Release date: 2024/11/18 |
Product Introduction
Bioactivity
Name | DSPE-PEG 2000 |
Description | DSPE-PEG 2000 is a non-toxic and biodegradable amphiphilic copolymer that can be used to form micelles to deliver nanoparticles. |
Storage | keep away from direct sunlight,keep away from moisture,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO : 60 mg/mL, Sonication is recommended. Ethanol : 20 mg/mL, Sonication is recommended. H2O : 20 mg/mL, Sonication is recommended. |
Inhibitors Related | Dihexadecyl hydrogen phosphate | NHLP-002 | DHAPC | NHLP-001 | DSPG sodium | Vaxfectin | 4A3-SC8 |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$59.00/2mg |
VIP3Y
|
TargetMol Chemicals Inc.
|
2024-10-23 | |
$0.00/1kg |
VIP4Y
|
WUHAN FORTUNA CHEMICAL CO., LTD
|
2024-07-26 | |
$0.00/1kg |
VIP5Y
|
Hebei Yanxi Chemical Co., Ltd.
|
2023-10-17 |
- Since: 2011-01-07
- Address: 36?Washington?Street, Wellesley?Hills
INQUIRY